Supporting Medicare Providers Act of 2022
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Supporting Medicare Providers Act of 2022 This bill extends a payment increase under Medicare's physician fee schedule through the end of 2023 (currently set to expire at the end of 2022).
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (64)
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Health Issues
Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act H.R.5526 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act HR 7391 Community Health Center Drug Pricing Protection Act HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act (Reconciliation 2.0) S 3014 Ensuring Timely Access to Generics Act of 2025 S 2355 Patients Deserve Price Tags Act HR 8646 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 HR 8800 National Defense Authorization Act for Fiscal year 2027 HR 9102 BINSA Bill COINS Act, enacted within P.L. 119-60 National Defense Authorization Act for Fiscal Year 2026 S 1414 Expedited Access to Biosimilars Act HR 10628/ S 5571 Biosimilars Access and Affordability Act S 5244 Sustain 340B Act HR 9599 Secure 340B Act HR 5509/ S 2903 Safe Step Act
Client expense: $3,150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Health Issues
Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act H.R.5526 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act HR 7391 Community Health Center Drug Pricing Protection Act HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act (Reconciliation 2.0) S 3014 Ensuring Timely Access to Generics Act of 2025 S 2355 Patients Deserve Price Tags Act HR 8646 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 HR 8800 National Defense Authorization Act for Fiscal year 2027 HR 9102 BINSA Bill COINS Act, enacted within P.L. 119-60 National Defense Authorization Act for Fiscal Year 2026 S 1414 Expedited Access to Biosimilars Act
2023 · third_quarter · Medicare/Medicaid
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act, S.2973 - Modernizing and Ensuring PBM Accountability Act, H.R.2880 - Protecting Patients Against PBM Abuses Act. Issues related to downcoding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Issues related to MACRA reform. Advocating for access to biosimilars. Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative); HR 5391, Protecting Patient Access to Cancer and Complex Therapies Act.
Client expense: Not reported · Firm income: $80,000
2023 · third_quarter · Medicare/Medicaid
Medicare Part B Reimbursement. Average Sales Price (ASP) generally (in the context of deficit reduction). Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 1770). Inflation Reduction Act. Supporting Medicare Providers Act (H.R.8800). Medicare Access & CHIP Reauthorization Act (MACRA). Pharmacy and Medically Underserved Areas Enhancement Act. Seniors Access to Critical Medicines Act (H.R. 5526). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages.
Client expense: $410,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Medicare/Medicaid
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative); HR 5391, Protecting Patient Access to Cancer and Complex Therapies Act.
Client expense: $27,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
| Republican |
| WV |
| Alma S. Adams | Democratic | NC |
| André Carson | Democratic | IN |
| Andy Harris | Republican | MD |
| Andy Kim | Democratic | NJ |
| Angie Craig | Democratic | MN |
| Ann M. Kuster | Democratic | NH |
| Beth Van Duyne | Republican | TX |
| Bill Johnson | Republican | OH |
| Bill Posey | Republican | FL |
| Brad Sherman | Democratic | CA |
| Bradley Scott Schneider | Democratic | IL |
| Brendan F. Boyle | Democratic | PA |
| Brian K. Fitzpatrick | Republican | PA |
| C. A. Dutch Ruppersberger | Democratic | MD |
| Chris Pappas | Democratic | NH |
| Chrissy Houlahan | Democratic | PA |
| Colin Z. Allred | Democratic | TX |
| Cynthia Axne | Democratic | IA |
| Daniel T. Kildee | Democratic | MI |
| David B. McKinley | Republican | WV |
| David G. Valadao | Republican | CA |
| David J. Trone | Democratic | MD |
| David N. Cicilline | Democratic | RI |
| David Scott | Democratic | GA |
| Dean Phillips | Democratic | MN |
| Debbie Lesko | Republican | AZ |
| Deborah K. Ross | Democratic | NC |
| Derek Kilmer | Democratic | WA |
| Diana DeGette | Democratic | CO |
| Don Bacon | Republican | NE |
| Doug Lamborn | Republican | CO |
| Ed Case | Democratic | HI |
| Elaine G. Luria | Democratic | VA |
| Eleanor Holmes Norton | Democratic | DC |
| Elissa Slotkin | Democratic | MI |
| Emanuel Cleaver | Democratic | MO |
| Eric A. "Rick" Crawford | Republican | AR |
| Eric Swalwell | Democratic | CA |
| G. K. Butterfield | Democratic | NC |
| Glenn Thompson | Republican | PA |
| Greg Pence | Republican | IN |
| Gus M. Bilirakis | Republican | FL |
| Guy Reschenthaler | Republican | PA |
| J. French Hill | Republican | AR |
| J. Luis Correa | Democratic | CA |
| Jackie Speier | Democratic | CA |
| James A. Himes | Democratic | CT |
| James R. Langevin | Democratic | RI |
| Jamie Raskin | Democratic | MD |
| Jared F. Golden | Democratic | ME |
| Jason Crow | Democratic | CO |
| Jay Obernolte | Republican | CA |
| Jefferson Van Drew | Republican | NJ |
| Jim Costa | Democratic | CA |
| Jimmy Gomez | Democratic | CA |
| Jimmy Panetta | Democratic | CA |
| Joe Neguse | Democratic | CO |
| John B. Larson | Democratic | CT |
| John Garamendi | Democratic | CA |
| John H. Rutherford | Republican | FL |
| John Joyce | Republican | PA |
| Joseph D. Morelle | Democratic | NY |
| Josh Gottheimer | Democratic | NJ |
| Josh Harder | Democratic | CA |
| Julia Brownley | Democratic | CA |
| Kathy Castor | Democratic | FL |
| Kim Schrier | Democratic | WA |
| Larry Bucshon | Republican | IN |
| Lisa Blunt Rochester | Democratic | DE |
| Lizzie Fletcher | Democratic | TX |
| Lori Trahan | Democratic | MA |
| Madeleine Dean | Democratic | PA |
| Mariannette Miller-Meeks | Republican | IA |
| Marilyn Strickland | Democratic | WA |
| Mark E. Green | Republican | TN |
| Mark Takano | Democratic | CA |
| Mary Sattler Peltola | Democratic | AK |
| Melanie A. Stansbury | Democratic | NM |
| Michael Guest | Republican | MS |
| Michael K. Simpson | Republican | ID |
| Mike Bost | Republican | IL |
| Mike Garcia | Republican | CA |
| Mike Thompson | Democratic | CA |
| Mikie Sherrill | Democratic | NJ |
| Nanette Diaz Barragán | Democratic | CA |
| Neal P. Dunn | Republican | FL |
| Nikema Williams | Democratic | GA |
| Nydia M. Velázquez | Democratic | NY |
| Patrick Ryan | Democratic | NY |
| Paul Tonko | Democratic | NY |
| Pete Aguilar | Democratic | CA |
| Pete Sessions | Republican | TX |
| Raja Krishnamoorthi | Democratic | IL |
| Randy Feenstra | Republican | IA |
| Raul Ruiz | Democratic | CA |
| Ron Kind | Democratic | WI |
| Ronny Jackson | Republican | TX |
| Salud O. Carbajal | Democratic | CA |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Sara Jacobs | Democratic | CA |
| Scott H. Peters | Democratic | CA |
| Sharice Davids | Democratic | KS |
| Stacey E. Plaskett | Democratic | VI |
| Stephen F. Lynch | Democratic | MA |
| Steve Cohen | Democratic | TN |
| Steven Horsford | Democratic | NV |
| Susan Wild | Democratic | PA |
| Ted Lieu | Democratic | CA |
| Tom O’Halleran | Democratic | AZ |
| Tony Cárdenas | Democratic | CA |
| Troy A. Carter | Democratic | LA |
Client expense: $2,440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
2023 · first_quarter · Health Issues
H.R. 1770: Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness and response; Healthcare innovation, ARPA-H, oncology research; H.R. 1835: Saving Access to Laboratory Services Act; Pandemic Response; Biden Cancer Moonshot Initiative; H.R.3258 Timely Access to Cancer Treatment Act; H.R.2163, S.464 The Safe Step Act; H.R. 8800 Supporting Medicare Providers Act of 2022; PAHPA reauthorization; Community health center fund reauthorization.
Client expense: $1,230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2023 · second_quarter · Medicare/Medicaid
Medicare Part B Reimbursement. Average Sales Price (ASP) generally (in the context of deficit reduction). International Pricing Index Model. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 1770). Most Favored Nation (MFN) policy. Inflation Reduction Act. Supporting Medicare Providers Act (H.R.8800). Medicare Access & CHIP Reauthorization Act (MACRA). Pharmacy and Medically Underserved Areas Enhancement Act.
Client expense: $450,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Medicare/Medicaid
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Client expense: $27,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
2023 · first_quarter · Medicare/Medicaid
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Client expense: $27,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Medicare/Medicaid
The Patient Protection and Affordable Care Act, Pub. L. No. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services, including budget neutrality and Medicare Economic Index; H.R.8800 - Supporting Medicare Providers Act of 2022; in general - protecting access to physician services for Medicare beneficiaries per preventing reductions resulting from Medicare sequestration, Statutory PAYGO, and reduction in Medicare conversion factor for CY2023; physician burden reduction under Medicare, in general; H.R.1868/Pub. L. No. 117-7, To prevent across-the-board direct spending cuts, and for other purposes/Medicare sequester; Policies to waive cost of certain diagnostic colorectal cancer procedures under Medicare; Policies to continue coverage and payment for telehealth services under Medicare; S.610/Pub. L. No. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act; H.R.3173/S.3018, Improving Seniors' Timely Access to Care Act; H.R.7995, To amend title XVIII of the Social Security Act to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans, and for other purposes; H.R.2617, the Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · first_quarter · Medicare/Medicaid
Medicare Part B Reimbursement. Average Sales Price (ASP) generally (in the context of deficit reduction). International Pricing Index Model. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. The Equitable Community Access to Pharmacist Services Act (H.R. 1770). Most Favored Nation (MFN) policy. Inflation Reduction Act. Supporting Medicare Providers Act (H.R.8800).
Client expense: $515,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Health Issues
H.R. 1770: Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness and response; Healthcare innovation, ARPA-H, oncology research; H.R. 1835: Saving Access to Laboratory Services Act; Pandemic Response; Biden Cancer Moonshot Initiative; H.R.3258 Timely Access to Cancer Treatment Act; H.R.2163, S.464 The Safe Step Act; H.R. 8800 Supporting Medicare Providers Act of 2022; PAHPA reauthorization; Community health center fund reauthorization.
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · third_quarter · Medicare/Medicaid
HR 8344: Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2022 Medicare sequestration moratorium Medicaid coverage and reimbursement Medicare wound care coverage National Correct Coding Initiative Edits Protection of programs related to physical therapy in deficit reduction Medicare Advantage Essential Health Benefits Medicare improvement standards Inclusion of physical therapists in quality programs Medicare Self-referral Coverage of telehealth under Medicare, Medicare Advantage, and Medicaid H.R. 2168/S. 3193 Expanded Telehealth Access Act APTA PT Outcomes Registry/Qualified Clinical Data Registries Medicare Quality Programs Accelerating Innovation in Medicine Act Improving Medicare Post-Acute Care Transformation Act Chronic Care Management Orthotics and Prosthetics H.R. 1990/S. 2556: Medicare Orthotics and Prosthetics Patient-Centered Care Act Medicare Private Contracting H.R. 3322/S. 826 Medicare Patient Empowerment Act Skilled Nursing Facility 3-Day rule H.R. 5536 Stabilizing Medicare Access to Rehabilitation and Therapy (SMART) Act PTA Differential in Medicare Prior Authorization in Medicare Advantage Plans Alternative payment models Health information technology: Electronic health records, health IT incentives for physical therapists, certification of EHRs interoperability, and information blocking durable medical equipment prosthetics orthotics and supplies competitive bidding H.R. 3630/S. 1315 Lymphedema Treatment Act Medicare enrollment Skilled Nursing Facility payment Home Health payment Medical review (Medicare) Reducing Health Care costs REAADI & DRMA Acts Home Health Payment Innovation Act H.R. 3173/S. 3018 Improving Seniors Timely Access to Care Act H.R. 3650/S. 2048 Improving Access to Medicare Coverage Act Critical Access Hospital Relief Act Medicare Fee Schedule Unified post-acute care prospective payment system Inpatient rehabilitation facilities / long term care hospital payment HIPAA proposed rule HR 6020 - Support Medicare Providers Act S. 3799 PREVENT Pandemics Act H.R. 5365 Primary Health Services Enhancement Act H.R. 8181 Optimizing Postpartum Outcomes Act H.R 8800 Supporting Medicare Providers Act of 2022
Client expense: $194,970 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
2022 · fourth_quarter · Health Issues
Pharmacist equitable access, health equity. H.R. 7213 Clinical trial diversity, health equity. H.R. 5030/S. 2706 Emergency preparedness and response. S. 3799 Healthcare innovation, ARPA-H, oncology research. H.R. 6000 Laboratory diagnostic services, schedule reimbursement S. 4449 Omnibus federal appropriations Pandemic Response Biden Cancer Moonshot Initiative H.R.3258 Timely Access to Cancer Treatment Act. H.R.2163, S.464 The Safe Step Act. H.R. 8800 Supporting Medicare Providers Act of 2022
Client expense: $810,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · third_quarter · Medicare/Medicaid
S. 4449/H.R. 8188 Saving Access to Laboratory Services Act H.R. 8800 Supporting Medicare Providers Act of 2022. Proposals related to Medicare coverage of continuous glucose monitors.
Client expense: $1,160,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Support H.R. 8800, Supporting Medicare Providers Act of 2022. This legislation provides a 4.42% update to the conversion factor. Support HR 7995, Gold Card Act'
Client expense: $326,542 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Barriers to further telehealth adoption in Medicare - eliminating originating site requirements; parity for telehealth and in-person visits Clinical labor data update in FY23 Physician Fee Schedule rule and resulting cuts. Develop new type of Medicare Coverage of Innovative Technologies proposal Medicare cuts to G2066, remote evaluation and review of data from implantable loop recorder systems. Legislation to stop or mitigate proposed cuts in the Medicare Physician Fee Schedule, including H.R. 8800, Supporting Medicare Providers Act) (whole)
Client expense: $540,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
Barriers to further telehealth adoption in Medicare - eliminating originating site requirements; parity for telehealth and in-person visits Clinical labor data update in FY22 Physician Fee Schedule rule and resulting cuts. HR 6048 - the Medicare Stability for Patients and Providers Act, in whole Develop new type of Medicare Coverage of Innovative Technologies proposal Medicare cuts to G2066, remote evaluation and review of data from implantable loop recorder systems. Legislation to stop or mitigate proposed cuts in the Medicare Physician Fee Schedule, including H.R. 8800, Supporting Medicare Providers Act) (whole)
Client expense: $640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
H.R.315-Medicare Sequester COVID Moratorium Act H.R.3650-Improving Access to Medicare Coverage Act of 2021 H.R.8800-Supporting Medicare Providers Act of 2022 H.R.8812-I CAN Act S.2048-Improving Access to Medicare Coverage Act of 2021 S.3314-Supporting Medicare Providers Act of 2021 S.5212-I CAN Act
Client expense: $515,937 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program. Support Congressional action to stop a pending 4.6% cut to Medicare physician payments in 2023 and action by Congress to waive PAYGO to prevent a 4 percent Medicare sequestration in 2023. Legislation to stop payment cuts H.R. 8800.
Client expense: Not reported · Firm income: $21,600
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Support the "Improving Seniors Timely Access to Care Act" (H.R. 3173 / S. 3018) increases transparency and streamlines prior authorization in the Medicare Advantage program. Support Congressional action to stop a pending 4.6% cut to Medicare physician payments in 2023 and action by Congress to waive PAYGO to prevent a 4 percent Medicare sequestration in 2023. Legislation to stop payment cuts H.R. 8800.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
H.R.8800 - Supporting Medicare Providers Act of 2022 - To amend title XVIII of the Social Security Act to extend certain increases in payments for physicians services under the Medicare program through 2023. S 3018 / HR 3173 - Seniors Timely Access to Care Act - To amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans, and for other purposes.
Client expense: $660,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
S.510 - Protecting Medicare and American Farmers from Sequester Cuts Act of 2021 HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 HR 3502 - Protecting People from Surprise Medical Bills Act HR 3630 - to amend title XXVII of the Public Health Service Act S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021 Prostate Cancer Misdiagnosis Elimination Act Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763 HR8800 - Supporting Medicare Providers Act HR3173/S3018 - Improving Seniors' Timely Access to Care Act HR8188- Saving Access to Laboratory Services Act
Client expense: $111,309 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Provider Enrollment; Medicare and Medicaid; Medicare-Medicaid for Primary Care; Reimbursement including Out-of-Network Reimbursement; Insurance Transparency; Prudent Layperson Standard; ACA (coverage of essential health benefits); Health Insurance Issues; LHHS; Surprise Billing; Medicare Physician Fee Schedule; HR 8800
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
2022 · fourth_quarter · Medicare/Medicaid
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; H.R. 5376, the Build Back Better Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Client expense: $27,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
S.834, Resident Physician Shortage Reduction Act: To provide additional Medicare funds to support 14,000 new GME/residency training slots S.3018, Improving Seniors Timely Access to Care Act: To streamline prior authorization in the Medicare Advantage Program H.R 2256, Resident Physician Shortage Reduction Act: To provide additional Medicare funds to support 14,000 new GME/residency training slots H.R.2617, Consolidated Appropriations Act, 2023: To prevent Medicare payment cuts, funding for additional Medicare GME slots and prior authorization reform, extending telehealth flexibilities H.R. 3173, Improving Seniors Timely Access to Care Act: To streamline prior authorization in the Medicare Advantage Program H.R. 8800, Protecting Medicare Providers Act: To prevent a 4.42% Medicare payment cut No Bill: To prevent Medicare payment cuts and mandate that the Centers for Medicare & Medicaid Services value global codes appropriately No Bill: Urging Congressional oversight and review of Medicare's Quality Payment Program No Bill: Urging Congress to repeal the Appropriate Use Criteria program for diagnostic imaging
Client expense: $35,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
S.834, Resident Physician Shortage Reduction Act: To provide additional Medicare funds to support 14,000 new GME/residency training slots S.3018, Improving Seniors Timely Access to Care Act: To streamline prior authorization in the Medicare Advantage Program H.R 2256, Resident Physician Shortage Reduction Act: To provide additional Medicare funds to support 14,000 new GME/residency training slots H.R.2617, Consolidated Appropriations Act, 2023: To prevent Medicare payment cuts, funding for additional Medicare GME slots and prior authorization reform, extending telehealth flexibilities H.R. 3173, Improving Seniors Timely Access to Care Act: To streamline prior authorization in the Medicare Advantage Program H.R. 8800, Protecting Medicare Providers Act: To prevent a 4.42% Medicare payment cut No Bill: To prevent Medicare payment cuts and mandate that the Centers for Medicare & Medicaid Services value global codes appropriately No Bill: Urging Congressional oversight and review of Medicare's Quality Payment Program No Bill: Urging Congress to repeal the Appropriate Use Criteria program for diagnostic imaging
Client expense: $35,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Budget/Appropriations
Monitor federal issues and legislation associated with health care policy. Monitor federal and legislative activity related to Medicare reimbursement. Monitor federal and legislative activity related to drug pricing. Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response. Monitoring and outreach on legislative and administrative activity related to infrastructure. Monitoring and outreach on legislative and administrative activity related to reconciliation and the congressional budget resolution. H.R. 4432 - Department of Defense Appropriations Act, FY2022. Senate Draft, Department of Defense Appropriations Act, FY2022 P.L. 116-136, CARES Act P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act P.L. 117-2, American Rescue Plan Act of 2021 H.R. 3684 - Infrastructure Investment and Jobs Act S. 464 - Safe Step Act H.R. 2163 - Safe Step Act H.R. 1319 - American Rescue Plan Act of 2021 S. 834 - Resident Physician Shortage Reduction Act of 2021 H.R. 2256 - Resident Physician Shortage Reduction Act of 2021 H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes H.R. 315 - Medicare Sequester COVID Moratorium Act S. 368 - Telehealth Modernization Act H.R. 1332 - Telehealth Modernization Act H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 S. 298 - Pharmacy Benefit Manager Accountability Study Act of 2021 S. 1024 - Healthcare Workforce Resilience Act H.R. 2255 - Healthcare Workforce Resilience Act H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act H.R. 3107 - The Improving Seniors Timely Access to Care Act H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act H.R. 315 - The Medicare Sequester COVID Moratorium Act S. 748 - Medicare Sequester Relief Act H.R. 5067 - Preserving Patient Access to Home Infusion Act S. 2652 - Preserving Patient Access to Home Infusion Act H.R. 3541 - Conrad State 30 and Physician Access Reauthorization Act S. 1810 - Conrad State 30 and Physician Access Reauthorization Act H.R. 5376 - Build Back Better Act S. 3314 - Supporting Medicare Providers Act H.R. 6020 - Supporting Medicare Providers Act H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act S. 4408 Health and Location Data Protection Act of 2022 H.R. 4122 - Resident Education Deferred Interest Act or the REDI Act S. 3658 - Resident Education Deferred Interest Act or the REDI Act H.R.8800 - Supporting Medicare Providers Act of 2022 S.5194 - Protecting Medicare Patients and Physicians Act H.R. 8800 - Protecting Medicare Patients and Physicians Act H.R.9424 - Creating Access to Residency Education Act of 2022 FY2023 Labor Health and Human Services Appropriations content Draft House, Department of Defense Appropriations Act, FY2023 Draft Senate, Department of Defense Appropriations Act, FY2023 Fiscal Year 2023 Omnibus
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Monitor federal issues and legislation associated with health care policy. Monitor federal and legislative activity related to Medicare reimbursement. Monitor federal and legislative activity related to drug pricing. Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response. Monitoring and outreach on legislative and administrative activity related to infrastructure. Monitoring and outreach on legislative and administrative activity related to reconciliation and the congressional budget resolution. H.R. 4432 - Department of Defense Appropriations Act, FY2022. Senate Draft, Department of Defense Appropriations Act, FY2022 P.L. 116-136, CARES Act P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act P.L. 117-2, American Rescue Plan Act of 2021 H.R. 3684 - Infrastructure Investment and Jobs Act S. 464 - Safe Step Act H.R. 2163 - Safe Step Act H.R. 1319 - American Rescue Plan Act of 2021 S. 834 - Resident Physician Shortage Reduction Act of 2021 H.R. 2256 - Resident Physician Shortage Reduction Act of 2021 H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes H.R. 315 - Medicare Sequester COVID Moratorium Act S. 368 - Telehealth Modernization Act H.R. 1332 - Telehealth Modernization Act H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 S. 298 - Pharmacy Benefit Manager Accountability Study Act of 2021 S. 1024 - Healthcare Workforce Resilience Act H.R. 2255 - Healthcare Workforce Resilience Act H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act H.R. 3107 - The Improving Seniors Timely Access to Care Act H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act H.R. 315 - The Medicare Sequester COVID Moratorium Act S. 748 - Medicare Sequester Relief Act H.R. 5067 - Preserving Patient Access to Home Infusion Act S. 2652 - Preserving Patient Access to Home Infusion Act H.R. 3541 - Conrad State 30 and Physician Access Reauthorization Act S. 1810 - Conrad State 30 and Physician Access Reauthorization Act H.R. 5376 - Build Back Better Act S. 3314 - Supporting Medicare Providers Act H.R. 6020 - Supporting Medicare Providers Act H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act S. 4408 Health and Location Data Protection Act of 2022 H.R. 4122 - Resident Education Deferred Interest Act or the REDI Act S. 3658 - Resident Education Deferred Interest Act or the REDI Act H.R.8800 - Supporting Medicare Providers Act of 2022 S.5194 - Protecting Medicare Patients and Physicians Act H.R. 8800 - Protecting Medicare Patients and Physicians Act H.R.9424 - Creating Access to Residency Education Act of 2022 FY2023 Labor Health and Human Services Appropriations content Draft House, Department of Defense Appropriations Act, FY2023 Draft Senate, Department of Defense Appropriations Act, FY2023 Fiscal Year 2023 Omnibus
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Monitor federal issues and legislation associated with health care policy. Monitor federal and legislative activity related to Medicare reimbursement. Monitor federal and legislative activity related to drug pricing. Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response. Monitoring and outreach on legislative and administrative activity related to infrastructure. Monitoring and outreach on legislative and administrative activity related to reconciliation and the congressional budget resolution. H.R. 4432 - Department of Defense Appropriations Act, FY2022. Senate Draft, Department of Defense Appropriations Act, FY2022 P.L. 116-136, CARES Act P.L. 116-260, FY2021 Omnibus and COVID Relief and Response Act P.L. 117-2, American Rescue Plan Act of 2021 H.R. 3684 - Infrastructure Investment and Jobs Act S. 464 - Safe Step Act H.R. 2163 - Safe Step Act H.R. 1319 - American Rescue Plan Act of 2021 S. 834 - Resident Physician Shortage Reduction Act of 2021 H.R. 2256 - Resident Physician Shortage Reduction Act of 2021 H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes H.R. 315 - Medicare Sequester COVID Moratorium Act S. 368 - Telehealth Modernization Act H.R. 1332 - Telehealth Modernization Act H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 S. 298 - Pharmacy Benefit Manager Accountability Study Act of 2021 S. 1024 - Healthcare Workforce Resilience Act H.R. 2255 - Healthcare Workforce Resilience Act H.R. 1819 - Pharmacy Benefit Manager Accountability Study Act H.R. 3107 - The Improving Seniors Timely Access to Care Act H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act H.R. 315 - The Medicare Sequester COVID Moratorium Act S. 748 - Medicare Sequester Relief Act H.R. 5067 - Preserving Patient Access to Home Infusion Act S. 2652 - Preserving Patient Access to Home Infusion Act H.R. 3541 - Conrad State 30 and Physician Access Reauthorization Act S. 1810 - Conrad State 30 and Physician Access Reauthorization Act H.R. 5376 - Build Back Better Act S. 3314 - Supporting Medicare Providers Act H.R. 6020 - Supporting Medicare Providers Act H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act S. 4408 Health and Location Data Protection Act of 2022 H.R. 4122 - Resident Education Deferred Interest Act or the REDI Act S. 3658 - Resident Education Deferred Interest Act or the REDI Act H.R.8800 - Supporting Medicare Providers Act of 2022 S.5194 - Protecting Medicare Patients and Physicians Act H.R. 8800 - Protecting Medicare Patients and Physicians Act H.R.9424 - Creating Access to Residency Education Act of 2022 FY2023 Labor Health and Human Services Appropriations content Draft House, Department of Defense Appropriations Act, FY2023 Draft Senate, Department of Defense Appropriations Act, FY2023 Fiscal Year 2023 Omnibus
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Pharmacist equitable access, health equity. H.R. 7213 Clinical trial diversity, health equity. H.R. 5030/S. 2706 Emergency preparedness and response. S. 3799 Healthcare innovation, ARPA-H, oncology research. H.R. 6000 Laboratory diagnostic services, schedule reimbursement S. 4449 Omnibus federal appropriations Pandemic Response Biden Cancer Moonshot Initiative H.R.3258 Timely Access to Cancer Treatment Act. H.R.2163, S.464 The Safe Step Act. H.R. 8800 Supporting Medicare Providers Act of 2022
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · fourth_quarter · Health Issues
Transparency. Copay Accumulators/Maximizers. Benefit Design. Quality-Adjusted Life Years. Home Health Services. National Coverage Determination H.R.5376 - Inflation Reduction Act of 2022. H.R.2163/S464 - Safe Step Act. H.R.3173/S.3018 - Improving Seniors Timely Access to Care Act. H.R.5801 - HELP Copays Act. H.R.7667 - Food and Drug Amendments of 2022. H.R.4472/S.373 - BENEFIT Act of 2021. H.R.7634 - Protecting Health Care for All Patients Act. H.R.8581/S.4605 - Preserving Access to Home Health Act. S.4348 - FDASLA Act of 2022. H.R.5067/S.2652 - Preserving Access to Home Infusion Act. H.R.8800 - Medicare Providers Act.
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Excellence in Mental Health and Addiction Treatment Act (S. 2069/ H.R. 4323), all provisions related to expanding and extending the Certified Community Behavioral Health Clinic Medicaid demonstration program. Mental Health Access Improvement Act (S. 828/H.R. 432), all provisions related to allowing marriage and family therapists and mental health counselors to directly bill Medicare for their services. Medicaid Reentry Act (H.R. 955/S. 285), all provisions related to allowing Medicaid coverage for eligible incarcerated individuals to be re-established up to 30 days before their release from jail or prison. Promoting Effective and Empowering Recovery Services in Medicare (PEERS) Act of 2021 (H.R. 2767), all provisions related to allowing peer support specialists to participate in behavioral health integration services under Medicare. Permanency for Audio-Only Telehealth Act (H.R. 3447), all provisions related to expanding access to audio-only telehealth under Medicare. Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act (H.R. 1647/S. 340), all provisions related to coverage of certain telehealth services under Medicare. Excellence in Recovery Housing Act (H.R. 2376/S. 2901), all provisions related to the availability of high-quality recovery housing for individuals with substance use disorders. Due Process Continuity of Care Act (H.R. 6636/S. 2697), all provisions related to the removal of the Medicaid coverage exclusion for inmates in custody pending disposition of charges. Supporting Medicare Providers Act of 2022 (H.R. 8800), all provisions related to the extension of certain increases in payments for physicians services under the Medicare program through 2023. Investing in Kids Mental Health Now Act of 2022 (S. 4747), all provisions related to the increase of payment rates for pediatric mental, emotional, and behavioral health services, including telehealth services, under Medicaid.
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare Reimbursement Policy; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023; Proton Therapy Reimbursement.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Medicare Reimbursement Policy; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023; Proton Therapy Reimbursement.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
The Patient Protection and Affordable Care Act, Pub. L. No. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services, including budget neutrality and Medicare Economic Index; H.R.8800 - Supporting Medicare Providers Act of 2022; in general - protecting access to physician services for Medicare beneficiaries per preventing reductions resulting from Medicare sequestration, Statutory PAYGO, and reduction in Medicare conversion factor for CY2023; physician burden reduction under Medicare, in general; H.R.1868/Pub. L. No. 117-7, To prevent across-the-board direct spending cuts, and for other purposes/Medicare sequester; Policies to waive cost of certain diagnostic colorectal cancer procedures under Medicare; Policies to continue coverage and payment for telehealth services under Medicare; S.610/Pub. L. No. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act; H.R.3173/S.3018, Improving Seniors' Timely Access to Care Act; H.R.7995, To amend title XVIII of the Social Security Act to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans, and for other purposes; H.R.2617, the Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; ; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R. 8800, Supporting Medicare Providers Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Medicare PAYGO Sequestration - (H.R 2617) - Supported inclusion of provisions in the Consolidated Appropriations Act to prevent 4% Medicare payment reductions due to sequestration required by statutory PAYGO requirements. Medicare Physician Reimbursement (H.R. 2617; H.R. 8800) - Supported legislation that would ease pending reimbursement cuts through the physician fee schedule conversion factor. Health Care Workforce (S.834/H.R. 2256; S. 1438/H.R. 3441; H.R. 2617) - Supported legislation to increase the number of Medicare-supported Graduate Medical Education slots. Advanced Alternative Payment Model (APM) Bonus Payment (H.R. 4587; H.R. 2617) - Supported passage of legislation to extend the APM bonus payments. Telehealth (H.R. 2617; H.R. 4040; S. 1512/H.R. 2903)- Advocated for Congress to extend or make permanent flexibilities related to distant site and geographic limitations, expanding the provider types and services available to be reimbursed by Medicare. Acute Hospital Care at Home Model (H.R. 2617; S. 3792/H.R. 7053) Supported passage of legislation to extend the Acute Hospital Care at Home Model beyond the end of the declared Public Health Emergency. Rural Health Care Extenders (H.R. 2617) - Supported extension of Medicare Dependent Hospital program and Medicare Low-Volume Adjustment. Mental and Behavioral Health (S. 4747; H.R. 7236; H.R. 2617) - Supported passage of legislation to better support access to mental and behavioral health needs for children and adults. Supported passage of the Improving Seniors' Timely Access to Care Act (S.3018/ H.R.3173). Supported passage of the Preserving Access to Home Infusion Act (H.R. 5067/S. 2652).
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
- Strong opposition to H.R. 8812, the Improving Care and Access to Nurses Act, or the I CAN Act. In general, we are deeply concerned that this broad, sweeping bill endangers the care of Medicare and Medicaid patients by expanding the types of services NPPs can perform and removing physician involvement in patient care under expanded scope of practice. - Request for Information on the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.Suggest actions Congress should take to stabilize the Medicare payment system while ensuring successful value-based care incentives are available for specialty physicians. ASDSA has serious concerns about structural and mounting instability in Medicare payments to physicians and request assistance in urging the committees of jurisdiction to hold hearings to begin the process of stabilizing and improving Medicare physician reimbursement and performance programs. - Applauds the introduction of H.R. 8800, the Supporting Medicare Providers Act of 2022. ASDSA strongly supports H.R. 8800 as an essential step toward providing clinicians with financial stability and ensuring patients have access to critical services our members provide. Steps must be taken to identify and advance systemic Medicare payment reforms designed to ensure longer‐term stability for clinicians, promote and reward value‐based care, advance health equity and reduce disparities within the Medicare system. - Letter to FDA, Center for Drug Evaluation and Research (CDER). We strongly ask that CDER office nominate a candidate who is board certified in dermatology when the time comes to fill the position of director of the Division of Dermatology and Dentistry at the FDA. We take note that few dermatologists currently serve in the Division and have specific concerns about how this may affect future decisions made regarding dermatologic surgery and patient safety. - Letter supporting the FDA as they work to finalize its proposed rules entitled General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products (Docket No. FDA-2015-N-1765); and the Sunlamp Products; Proposed Amendment to Performance Standard (Docket No. FDA-1998-N-0880) We are deeply concerned that the publics health continues to be at risk due to insufficient sunlamp regulation and believe the public would greatly benefit from FDAs finalizing these proposed rules. We strongly encourage the FDA to expeditiously finalize rules to restrict minors use of sunlamps, to require risk acknowledgement certification from adults, and to strengthen the sunlamp performance standards. - Alongside National Council on Skin Cancer Prevention (NCSCP), ASDSA requests that the Food and Drug Administration, working with the Department of Health and Human Services, finalize the proposed rules entitled General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products (Docket No. FDA-2015-N-1765); and the Sunlamp Products; Proposed Amendment to Performance Standard (Docket No. FDA-1998-N-0880) published by the FDA in the Federal Register on December 22, 2015. We request to meet with FDA and look forward to continuing our collaboration in furtherance of protecting the publics health.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
2022 · fourth_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic disease and disorders Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations Issues related to telemedicine/telehealth COVID-19 vaccination policies/prioritization Resident Physician Shortage Reduction Act (H.R. 2256/S. 834) Healthcare Workforce Resilience Act (H.R. 2255/S. 1024) Cures 2.0 Act (H.R. 6000) Sickle cell disease/trait issues Sickle Cell Disease Comprehensive Care Act (H.R. 6216 / S.3389) Prior authorization Improving Seniors Timely Access to Care Act (H.R. 3173/S. 3018) Advancing Telehealth Beyond COVID Act (H.R. 4040) Supporting Medicare Providers Act (H.R. 8800) FY2023 Consolidated Appropriations Act (H.R. 2617)
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
Client expense: $140,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE